DIFÚZE INJEKTOVANÉ KOLAGENÁZY CLOSTRIDIUM HISTOLYTICUM U DUPUYTRENOVY NEMOCI: STUDIE IN VIVO
Autoři:
T. Kanatani 1; I. Nagura 2; Y. Harada 1; S. Lucchina 3,4
Působiště autorů:
Department of Orthopedic Surgery, Kobe Rosai Hospital, Kobe, Japan
1; Department of Orthopedic Surgery, Ako City Hospital, Ako, Japan
2; Locarno Hand Center, Locarno, Switzerland
3; Hand Unit – Locarno’s Regional Hospital, Locarno, Switzerland
4
Vyšlo v časopise:
ACTA CHIRURGIAE PLASTICAE, 62, 3-4, 2020, pp. 60-63
Zdroje
1. Badalamente MA., Stern L., Hurst LC. The pathogenesis of Dupuytren’s contracture: contractile mechanisms of the myofibroblasts. J Hand Surg Am. 1983, 8:235–43.
2. Diep GK., Agel J., Adams JE. Prevalence of palmar fibromatosis with and without contracture in asymptomatic patients. J Plast Surg Hand Surg. 2015. 49:247–50.
3. Degreef I., De Smet L. A high prevalence of Dupuytren´s disease in Flanders. Acta Orthop Belg. 2010. 76:316–20.
4. Lanting R., van den Heuvel ER., Westerink B., Werker PM. Prevalence of Dupuytren disease in The Netherlands. Plast Reconstr Surg. 2013, 132:394–403.
5. Crean SM., Gerber RA., Le Graverand MP., Boyd DM., Cappelleri JC. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren´s contracture in European patients: a structured review of published studies. J Hand Surg Eur. 2011, 36:396–407.
6. Badalamente MA., Hurst LC., Benhaim P., Cohen BM. Efficacy and safety of CCH in the treatment of proximal interphalangeal joints in Dupuytren contracture: combined analysis of 4 phase 3 clinical trials. J Hand Surg Am. 2015, 40:975–83.
7. Gaston RG., Larsen SE., Pess GM., et al. The Efficacy and Safety of Concurrent CCH Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study. J Hand Surg Am. 2015, 40:1963–71.
8. Gilpin D., Coleman S., Hall S., Houston A., Karrasch J., Jones N. Injectable CCH: a new nonsurgical treatment for Dupuytren´s disease. J Hand Surg Am. 2010, 35:2027–38.e1
9. Hirata H., Tanaka K., Sakai A., Kakinoki R., Ikegami H., Tateishi N. Efficacy and safety of CCH injection for Dupuytren´s contracture in non-Caucasian Japanese patients (CORD-J Study): the first clinical trial in a non-Caucasian population. J Hand Surg Eur. 2017, 42:30–8.
10. Hurst LC., Badalamente MA., Hentz VR., et al. Injectable CCH for Dupuytren´s contracture. N Engl J Med. 2009, 361:968–79.
11. Desai SS., Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am. 2011, 36:936–42.
12. Zhang AY., Curtin CM., Hentz VR. Flexor tendon rupture after collagenase injection for Dupuytren contracture: case report. J Hand Surg Am. 2011, 36:1323–5.
13. Xiaflex (CCH) [package insert].Or Malvern, PA: Auxilium Pharmaceuticals, Inc.; 2016.
14. Shelanski KA., Shelanski MV. PVP-iodine: history, toxicity and therapeutic uses. J Int Coll Surg. 1956, 25:727–34.
15. Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg. 1986, 151:400–6.
16. Sindelar WF., Mason GR. Efficacy of povidone-iodine irrigation in prevention of surgical wound infections. Surg Forum. 1977, 28:48–51.
17. Chundamala J., Wright JG. The efficacy and risks of using povidone-iodine irrigation to prevent surgical site infection: an evidence-based review. Can J Surg. 2007, 50:473–81.
18. Kanatani T., Nagura I., Harada Y. CCH Injection with Precise Needle Length Adjusted by Silicone Tube Interposition for Dupuytren Contracture. J Hand Surg Asian Pac Vol. 2018, 23:437–9.
19. Verheyden JR. Early outcomes of a sequential series of 144 patients with Dupuytren´s contracture treated by collagenase injection using an increased dose, multi-cord technique. J Hand Surg Eur. 2015, 40:133–40.
20. Leclère FM., Mathys L., Vögelin E. Traitement de la maladie de Dupuytren par collagénase injectable, évaluation de l´échographie assistée [Collagenase injection in Dupuytren´s disease, evaluation of the ultrasound assisted technique]. Chir Main. 2014, 33:196–203.
21. Crivello KM., Potter HG., Moon ES., Rancy SK., Wolfe SW. Does collagenase injection disrupt or digest the Dupuytren´s cord: a magnetic resonance imaging study. J Hand Surg Eur. 2016, 41:614–20.
Štítky
Chirurgie plastická Ortopedie Popáleninová medicína TraumatologieČlánek vyšel v časopise
Acta chirurgiae plasticae
2020 Číslo 3-4
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Neodolpasse je bezpečný přípravek v krátkodobé léčbě bolesti
- Léčba akutní pooperační bolesti z pohledu ortopeda
Nejčtenější v tomto čísle
- DIFÚZE INJEKTOVANÉ KOLAGENÁZY CLOSTRIDIUM HISTOLYTICUM U DUPUYTRENOVY NEMOCI: STUDIE IN VIVO
- HIRUDOTERAPIE V REKONSTRUKČNÍ CHIRURGII: KAZUISTIKY A REVIEW
- FUNKČNÍ REKONSTRUKCE MĚKKOTKÁŇOVÝCH OROFACIÁLNÍCH DEFEKTŮ MIKROVASKULÁRNÍM LALOKEM MUSCULUS GRACILIS
- DERMÁLNÍ NÁHRADA MATRIDERM® – PRVNÍ ZKUŠENOSTI NA KLINICE POPÁLENINOVÉ MEDICÍNY 3. LF UK A FNKV